These CAGGCre-ERTM transgenic mice have widespread expression of a tamoxifen-inducible Cre recombinase.
IMR Colony, The Jackson Laboratory
Genetic Background | Generation |
---|---|
|
Allele Type |
---|
Transgenic (Recombinase-expressing, Inducible) |
These CAGGCre-ERTM transgenic mice have a tamoxifen-inducible cre-mediated recombination system driven by the chicken beta actin promoter/enhancer coupled with the cytomegalovirus (CMV) immediate-early enhancer. When bred with mice containing loxP-flanked sequences, tamoxifen-inducible Cre-mediated recombination results in deletion of the floxed sequences in widespread cells/tissues of the offspring. Tamoxifen administration will also induce Cre recombination in developing embryos of treated mothers and in cultured cells derived from transgenic mice. Homozygous mice are not viable or fertile. Heterozygous mutant mice are viable, fertile, normal in size and do not display any gross physical or behavioral abnormalities.
The CreERTM fusion protein consists of Cre recombinase fused to a G525R mutant form of the mouse estrogen receptor; which does not bind its natural ligand (17β-estradiol) at physiological concentrations but will bind the synthetic estrogen receptor ligands 4-hydroxytamoxifen (OHT or tamoxifen) and, with lesser sensitivity, ICI 182780. Restricted to the cytoplasm, Cre-ERT can only gain access to the nuclear compartment after exposure to tamoxifen. To counteract the mixed estrogen agonist effects of tamoxifen injections, which can result in late fetal abortions in pregnant mice, progesterone may be coadministered.
In an attempt to offer alleles on well-characterized or multiple genetic backgrounds, alleles are frequently moved to a genetic background different from that on which an allele was first characterized. This is the case for these FVB/N-congenic CAGGCre-ERTM mice. It should be noted that the phenotype of these mice could vary from that originally described. We may modify the FVB/N-congenic CAGGCre-ERTM strain description if necessary as published results become available.
The pCAGGCre-ERTM transgene was designed with the CMV-IE enhancer/chicken β-actin/rabbit β-globin hybrid promoter (CAG; originally from the pCAGGS vector) and CreERTM fusion gene (CreERTM; Cre recombinase fused to a G525R mutant form of the mouse estrogen receptor ligand binding domain). The transgene was introduced into B6CBF1 donor eggs. The resulting transgenic males were backcrossed for two generations on the SWR background. In 2002, transgenic mice were sent to The Jackson Laboratory Repository (as Stock No. 004453). In 2003, some of the transgenic mice were backcrossed to C57BL/6J inbred mice (Stock No. 000664) for at least five generations to generate a C57BL/6J-congenic line (Stock No. 004682). In 2012, some of the C57BL/6J-congenic mice were subsequently backcrossed to FVB/NJ inbred mice (Stock No. 001800) for several generations using a marker-assisted, speed congenic approach to generate this FVB/NJ-congenic strain (Stock No. 017595).
Expressed Gene | cre/Esr1, Cre recombinase and estrogen receptor 1 fusion gene, |
---|---|
Site of Expression | tamoxifen-inducible cre; widespread pattern of expression; tamoxifen administration will also induce Cre recombination in developing embryos of treated mothers and in cultured cells derived from transgenic mice |
Allele Name | transgene insertion 5, Andrew P McMahon |
---|---|
Allele Type | Transgenic (Recombinase-expressing, Inducible) |
Allele Synonym(s) | CAG-CreEr; CAGG-Cre; CaggCreER; CAGGCre-ER; CAGGCre-ERTM; CAGGCre-ERtm line 5.8; CAGGS-CreER; CAGGS-CreErT; CMV-creERT; Cre-ER; Cre-ERTM; CreESRT; ER-cre; Tg(CAG-cre/Esr1)5Amc; Tg(cre/Esr1)5Amc; Tg:Cag-Cre/Esr1; TgCreER; TgCAGGCreER; uCreERT |
Gene Symbol and Name | Tg(CAG-cre/Esr1*)5Amc, transgene insertion 5, Andrew P McMahon |
Gene Synonym(s) | |
Promoter | ACTB, actin, beta, chicken |
Expressed Gene | cre/Esr1, Cre recombinase and estrogen receptor 1 fusion gene, |
Site of Expression | tamoxifen-inducible cre; widespread pattern of expression; tamoxifen administration will also induce Cre recombination in developing embryos of treated mothers and in cultured cells derived from transgenic mice |
Strain of Origin | (C57BL/6 x CBA)F1 |
Chromosome | UN |
General Note | Homozygous transgenic mice are not viable or fertile. Hemizygous transgenic mice are viable, fertile, normal in size and do not display any gross physical or behavioral abnormalities. In transgenic mice the mutant mouse estrogen receptor does not bind natural ligand at physiological concentrations but will bind the synthetic ligand, 4-hydroxytamoxifen. Restricted to the cytoplasm, the Cre/Esr1 fusion protein can only gain access to the nuclear compartment after exposure to tamoxifen. When crossed with a strain containing loxP sites flanking a sequence of interest, tamoxifen induced, Cre-mediated targeted deletions are generated in the offspring. Tamoxifen administration will induce Cre recombination in developing embryos of treated mothers and in cultured cells derived from transgenic mice. Note that this transgene does not contain the cre/ERT2 fusion but was mistakenly referred to by the synonym CAG-CreERT2 in publication. J:136965 Note that this transgene does not contain the cre/ERT2 fusion but was mistakenly referred to by the synonym CAGG-CreERT2 in publication. J:130851 |
Molecular Note | This transgene expresses a fusion protein consisting of Cre recombinase joined to the ligand-binding domain of a mouse estrogen receptor modified to bind to 4-hydroxytamoxifen, but not to endogenous estrogen. The CAG promoter, containing a chicken beta actin promoter/enhancer coupled with the cytomegalovirus immediate-early (CMV-IE) enhancer, drives high levels of expression in most tissues. In the presence of tamoxifen, the fusion protein is transported into the nucleus, where cre can excise loxP-flanked segments from conditionally modified genes. |
Mutations Made By | Shigemi Hayashi, Columbia University |
These mice were bred to FVB/NJ inbred mice (Stock No. 001800) for many generations using a marker-assisted, speed congenic approach to generate this FVB/NJ-congenic strain. When maintaining the live congenic colony, carrier mice may be bred with wildtype (noncarrier) mice from the colony or with FVB/NJ inbred mice.
When using the CAGGCre-ERTM mouse strain in a publication, please cite the originating article(s) and include JAX stock #017595 in your Materials and Methods section.
Facility Barrier Level Descriptions
Service/Product | Description | Price |
---|---|---|
Hemizygous or Non carrier for Tg(CAG-cre/Esr1*)5Amc |
Frozen Mouse Embryo | FVB.Cg-Tg(CAG-cre/Esr1*)5Amc/J Frozen Embryo | $2595.00 |
Frozen Mouse Embryo | FVB.Cg-Tg(CAG-cre/Esr1*)5Amc/J Frozen Embryo | $2595.00 |
Frozen Mouse Embryo | FVB.Cg-Tg(CAG-cre/Esr1*)5Amc/J Frozen Embryo | $3373.50 |
Frozen Mouse Embryo | FVB.Cg-Tg(CAG-cre/Esr1*)5Amc/J Frozen Embryo | $3373.50 |
Terms are granted by individual review and stated on the customer invoice(s) and account statement. These transactions are payable in U.S. currency within the granted terms. Payment for services, products, shipping containers, and shipping costs that are rendered are expected within the payment terms indicated on the invoice or stated by contract. Invoices and account balances in arrears of stated terms may result in The Jackson Laboratory pursuing collection activities including but not limited to outside agencies and court filings.
The Jackson Laboratory has rigorous genetic quality control and mutant gene genotyping programs to ensure the genetic background of JAX® Mice strains as well as the genotypes of strains with identified molecular mutations. JAX® Mice strains are only made available to researchers after meeting our standards. However, the phenotype of each strain may not be fully characterized and/or captured in the strain data sheets. Therefore, we cannot guarantee a strain's phenotype will meet all expectations. To ensure that JAX® Mice will meet the needs of individual research projects or when requesting a strain that is new to your research, we suggest ordering and performing tests on a small number of mice to determine suitability for your particular project. We do not guarantee breeding performance and therefore suggest that investigators order more than one breeding pair to avoid delays in their research.
What information were you hoping to find through your search?
How easy was it to find what you were looking for?
We may wish to follow up with you. Enter your email if you are happy for us to connect and reachout to you with more questions.
Please Enter a Valid Email Address
Thank you for sharing your feedback! We are working on improving the JAX Mice search. Come back soon for exciting changes.